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Abstract
Advanced Glycated End Products (AGEs) are formed by non-enzymatic protein glycation and are implicated in several
physiological aspects including cell aging and diseases. Recent data indicate that bacteria – although short lived – produce,
metabolize and accumulate AGEs. Here we show that Escherichia coli cells secret AGEs by the energy-dependent efflux
pump systems. Moreover, we show that in the presence of these AGEs there is an upshift of pro-inflammatory cytokins by
mammalian cells. Thus, we propose that secretion of AGEs by bacteria is a novel avenue of bacterial-induced inflammation
which is potentially important in the pathophysiology of bacterial infections. Moreover, the sensing of AGEs by the host
cells may constitute a warning system for the presence of bacteria.
Citation: Cohen-Or I, Katz C, Ron EZ (2011) AGEs Secreted by Bacteria Are Involved in the Inflammatory Response. PLoS ONE 6(3): e17974. doi:10.1371/
journal.pone.0017974
Editor: Anne Charlotte Gruner, Agency for Science, Technology and Research (A*STAR), Singapore
Received October 28, 2010; Accepted February 17, 2011; Published March 22, 2011
Copyright:  2011 Cohen-Or et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: CK was supported by a fellowship of the Alfried Krupp Wissenschaftskolleg Greifswald. The funder had no role in study design, data collection and
analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: eliora@post.tau.ac.il
. These authors contributed equally to this work.
Introduction
Protein glycation is a process in which reducing sugars interact
with primary amines on the side chains of lysine and arginine,
resulting in a chemical sequence of reactions known as ‘‘Amadori
rearrangement’’ which leads to the formation of Amadori-
modified proteins (AMPs). AMPs are reversible intermediates of
glycation processes, and several mechanisms involved in their
catabolism have been described [1,2,3,4,5]. However, AMPs can
further developed, in an oxidation-dependent manner, to form
irreversible, highly stable compounds known as Advanced
Glycation End-products (AGEs).
AGEs were shown to participate in the pathophysiology of
several age-related diseases [6,7,8,9]. They interact with specific
receptors which mediate intracellular signaling that leads to
enhanced oxidative stress and elaboration of key pro-inflammatory
cytokines [3,10,11,12]. Several AGEs receptors have been
identified, including macrophage scavenger receptors Types I
and II, and are expressed on a wide range of cells [13]. Of special
interest is RAGE (Receptor for AGEs) which is involved in
inflammation and sepsis. Thus, reduction of RAGE activity by
genetic manipulations or anti-RAGE antibodies, was shown to
reduce inflammation and protects from sepsis in a murine model
[14,15].
AGEs also exist in bacteria [16] and in E. coli they are
metabolized and accumulate as low molecular weight compounds
[17]. Here we show that E. coli cells secrete AGEs by an active,
energy-dependent system which is carried out by the efflux
pumps system. Moreover, we show that the secreted AGEs
participate in the inflammation response of mammalian cell
cultures, indicating that they play a role in the phatophisiology of
bacterial infections.
Results
AGEs are secreted
The intracellular concentrations of AGEs are relatively steady,
but with time there is a dramatic accumulation of AGEs in the
medium, (Figure 1A). This finding is based on monitoring the
fluorescent fraction of secreted AGEs, which has the typical peak
at 440 nm and a broad spectrum, reflecting the heterogeneity of
the fraction (see insert of Figure 1A). Based on size-exclusion
filtration we determined that the extracellular AGEs are smaller
than 3 kD. This finding is compatible with the assumption that
they originate from catabolism of protein glycation products [17].
The concentration of AGEs in the supernatant are considerably
higher than these of the intracellular AGEs, suggesting that the
intracellular concentration is maintained constant by secreting the
excess. This assumption is further supported by the finding that
the secretion of AGEs is enhanced under oxidative conditions,
which stimulates the oxidation-dependent formation of AGEs.
Thus, the addition of the oxidative agent N,N9-dimethyl-4,49-
bipyridinium dichloride (Paraquat, Sigma) resulted in a significant
increase in secreted AGEs (Figure 1B).
AGEs are secreted in their mature form
The presence of AGEs in the medium can result from a
secretion process of AGEs which are formed inside the bacteria,
alternatively, it is possible that the intermediates of AGEs are
secreted and the formation of AGEs is taking place outside the
cells. To distinguish between these two possibilities we deter-
mined the potential of AGEs formation in the intracellular and
extracellular fractions, taking advantage of the fact that
fluorescent AGEs are formed by cross-linking of corresponding
Amadori-products intermediates. Bacterial lysates and secreted
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PBS buffer and AGEs-specific fluorescence was measured every
30 minutes.
In the intracellular fraction (bacterial lysates), the AGEs-specific
fluorescence increased with time reaching over 6 fold of the basal
level. In contrast, in the extracellular fraction, fluorescence
Figure 1. Kinetic studies of AGEs formation and secretion. Bacterial growth and sample collection were described in materials and methods.
AGEs-specific fluorescence (Ex. 370, Em. 440) was determined and normalized to cells density. A) AGEs-specific fluorescence during growth in the
intracellular and extracellular fractions. The insert shows the distribution of AGEs with excitation at 370 nm. B) Effect of 5 mM paraquat on
Extracellular accumulation of AGEs. C–D) Kinetics of AGEs formation in vitro. Bacteria were separated from extracellular fractions and sonicated
(intracellular fraction). C) The intracellular and D) extracellular fractions were incubated at 37uC and AGEs-specific fluorescence was determined every
30 minutes (Ex. 370, Em. 440–500). Effect of E) 2 mM DTT or F) 50 mM aminoguanidine on AGES in the intracellular fractions. All data represent three
independent experiments, in Figures C–F a representative result is shown.
doi:10.1371/journal.pone.0017974.g001
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added to the intracellular fraction to prevent development of
AGEs, since AGEs formation is oxidation depended. Indeed,
addition of 2 mM DTT resulted in a considerable decrease in the
rate of AGEs formation (Figure 1E) Moreover, addition of 50 mM
aminoguanidine, an agent known to prevent the essential cross-
linking in AGEs formation [18] completely abolished AGEs
accumulation (Figure 1F). These results demonstrate that
intermediates of AGEs formation are restricted to the intracellular
fraction and that the secreted molecules are ‘‘mature’’ AGEs.
Accumulation of AGEs requires protein synthesis and
energy
AGEs are the end product of protein glycation processes. In
order to determine whether the secretion of AGEs is dependent on
protein synthesis we examined the effect of a translational arrest
on the kinetics of AGEs secretion. The results presented in
Figure 2A demonstrate that following translational arrest by
chloramphenicol the intracellular concentration of AGEs is
depleted. Concurrently, the concentration of AGEs in the
extracellular fraction increases, suggesting that production of
AGEs, but not their secretion, is blocked in the absence of protein
synthesis. In the presence of chloramphenicol the accumulation of
extracellular AGEs reaches a plateau, which is at a lower value
than without translational arrest, indicating that new AGEs are
not formed in the absence of translation (Figure 2B).
An even more drastic decrease in the level of AGEs in the
medium was obtained when arsenate was added to deplete
internal ATP levels (Figure 2B). Part of this effect is due to the
requirement of ATP for protein synthesis. However, the finding
that ATP depletion has a stronger effect than a translational arrest
indicates the involvement of additional energy dependent
processes.
AGEs are secreted by the efflux pumps system
The finding that AGEs secretion is ATP dependent (Figure 2B),
suggests the involvement of an active pumps system in their
secretion. Active efflux systems – efflux pumps – are present in all
living cells and are responsible for extrusion of toxic substances and
antibiotics outside the cell in an energy-dependent manner [3]. The
efflux pumps decreases the antibacterial activity of many unrelated
drug families and can be considered as a ‘general’ resistance
mechanism and thus contribute to bacterial multidrug resistance
(MDR) [19,20]. To examine this possibility we used 1-(1-
Naphthylmethyl)-piperazine - an efflux pumps inhibitor that has
beenshown toreversemultidrugresistance(MDR) inE. coli [21,22].
Indeed, there was a clear concentration-dependent inhibitory effect
of the efflux pump inhibitor on secretion of AGEs (Figure 3A).
In order to further examine the rule of the efflux pump systems
in the secretion of AGEs, we constructed a tolC deletion strain
(DtolC) and studied its effect. TolC is an outer membrane protein
known to participate in the activity of wide variety of efflux pumps.
TolC is involved in the export of chemically diverse molecules
ranging from large protein toxins to small toxic compounds, such
as antibiotics [22,23]. TolC mutants were shown to be highly
sensitive to a wide variety of organic compounds demonstrating its
secretion deficiency [24,25]. The DtolC mutant showed a
dramatically reduced secretion of AGEs (Figure 3B) indicating
the involvement of TolC in this process.
AGEs secreted from bacteria cause inflammation in
human cells
Endogenous AGEs cause inflammation through interaction with
specific receptors (RAGE) [13]. As an example, THP-1 monocytic
cells respond to AGEs by production of cytokines [26]. Our
findings that bacteria secrete AGEs suggested the possibility that
these AGEs can be involved in the inflammation processes.
Indeed, exposure of THP-1 cells to AGEs-containing fractions
resulted in an increase of TNF-alpha secretion. The magnitude of
the inflammatory response was proportional to the levels of AGEs
in the fraction (Figure 4A).
The levels of the pro-inflammatory cytokine TNF-alpha were
considerably reduced under conditions resulting in reduced
secretion of bacterial AGEs, i.e., upon inhibition of the bacterial
efflux pumps by peprazine or by deleting the efflux pumps
component TolC (Figure 4B). These results demonstrate the
strong correlation between the levels of AGEs in the extracellular
fraction and THP-1 inflammatory response and emphasize the
ability of AGEs secreted by bacteria to induce inflammation in
mammalian cells.
Figure 2. Effect of protein synthesis arrest on AGEs secretion. Bacteria were grown in MOPS minimal medium and samples were collected for
AGEs determination as described in materials and methods. AGEs-specific fluorescence (Ex. 370, Em. 440) was determined and normalized to cells
density. A) Intracellular and extracellular AGEs levels following exposure to chloramphenicol. B) Effect of chloramphenicol (open circles) and Arsenate
(triangles) on AGEs secretion kinetics. The data represent three independent experiments.
doi:10.1371/journal.pone.0017974.g002
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The bacterial-host interactions involve a recognition process in
which each of the partners senses the presence of the other. This
sensing results in a cascade of molecular and biochemical reactions
aimed at adapting to the new situation. Here we provide evidence
that bacteria secrete protein glycation products (AGEs) which are
sensed by mammalian cells and trigger the inflammation cascade.
AGEs are ubiquitous irreversible end products of protein
glycation which are formed from Amadouri protein products. We
previously demonstrated that AGEs are formed and metabolized in
E.coli and that theiraccumulationis deleterious. Here weshowthat
AGEsaresecreted byE.coli, suggestinga mechanismfordisposalof
these irreversible protein glycation products from the cells. A
cellular mechanism responsible for secretion of AGEs in higher
organisms has not been described yet, however there are evidence
indicating that in diabetic patients, AGEs are excreted in the urine
[27,28], demonstrating a systemic removal of glycation products
and probably reflecting a universal need for their removal.
Inhibition of protein synthesis by chloramphenicol dramatically
reduced AGEs accumulation in the medium indicating that AGEs
formation is dependent on protein synthesis. We hypothesize that
under normal growth conditions new proteins are constantly
synthesized and glycated, while when the synthesis of new proteins
ceased, glycation is limited by existing pool of proteins. When ATP
production was disrupted by arsenate, AGEs accumulation in the
medium was further reduced, indicating that another ATP
dependent mechanism is involves in AGEs formation or secretion.
Our finding that the efflux pumps system play a role in this process
presents an additional mechanism in which ATP is involved.
However it is possible that other processes in the pathway of AGEs
synthesis and secretion requires energy.
Inflammation is a cellular response designated to protect the
host against invading pathogens. The innate immune system is
able to detect pathogens via a limited number of pattern-
recognition receptors [29,30]. In addition, inflammation can also
occur in response to intracellular signals. In mammalians, AGEs
were shown to mediate intracellular signaling that leads to
Figure 3. Effect of an efflux pumps inhibitor and tolC deletion mutant on AGEs secretion. Effect of A) 50 ng/ml and 100 ng/ml of
piperazine or B) tolC deletion on the kinetics of AGEs secretion. The data represent three independent experiments.
doi:10.1371/journal.pone.0017974.g003
Figure 4. Effect of extracellular AGEs on secretion of TNF-alpha by THP-1 cells. The levels of TNF-alpha secreted by THP-1 cells were
measured using sandwich-ELISA (see methods). A) TNF-alpha levels following exposure to elevated concentration of AGEs-containing fraction. B)
Relative TNF-alpha levels secreted from THP-1 cells following exposure to the extracellular fractions (1/80 stock dilutions in distilled water) secreted
from wild type cells, peprazine-treated cells and Dtolc mutant cells. The data represent three independent experiments.
doi:10.1371/journal.pone.0017974.g004
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cytokines [10,11,12,3].
Exposure of human THP-1 cells to E. coli supernatant resulted in
induction of cellular inflammation. The level of the inflammatory
response was highly correlated with the concentration of AGEs in
the medium. This result suggests that AGEs secreted by bacteria
maybesensedbymammaliancells,and presenta possiblemodelfor
the involvement of the Receptor for AGEs (RAGE) in bacterial
infection and sepsis. Here we suggest a new role for RAGE as a
detector of bacterial metabolites and, thus, bacterial presence.
To conclude, we show that AGEs are formed in bacteria as the
end product of protein glycation processes and are actively
secreted into the medium. We propose that RAGE-expressing cells
can detect these AGEs and activate the immune system leading to
enhanced inflammatory response. Thus, RAGE may functions as
sensor for bacterial invasion.
Materials and Methods
Bacterial strains and growth conditions
The E. coli K12 wild type strain MG1655 was used throughout.
Its tolC deletion (DtolC) was constructed by the one step
inactivation system as described previously [31]. Cultures were
grown with aeration at 37uC to the exponential growth phase in
MOPS minimal medium [32] supplemented with 0.2% glucose.
Sample preparation
Extracellular fractions were separated from the bacteria using
centrifugation and 0.2 mm filtration (Sartorius Stedim biotech) and
AGEs were determined in the cells (sonicated) and in the
supernatant. When required cultures were treated with 100 mg/
ml chloramphenicol (Sigma) or 50 mg/ml arsenate (Sigma). In
experiments involving determination of AGEs in non-growing cells
(Figure 1B, and Figure 3) cultures were washed and brought to the
same turbidity in glucose-free media and incubated for two hours.
For determination of inflammation, bacteria (2610
8/ml) were
washed and incubated for 2 h in glucose free MOPS. AGEs-
containing supernatant samples were concentrated 20 fold using
Speed-Vac and used as stock solution.
Determination of AGEs
AGEs were quantified using the natural AGE-specific fluores-
cence (Ex. 370 nm, Em. 440 nm) by scanning emission ranging
from 400 nm to 500 nm upon excitation at 370 nm at 37uC, in a
HORIBA scientific FluoroLog-3 Spectrofluorometer. Data repre-
sent either the full range spectrum, or the 440 nm emission peak,
as indicated in the legends.
Cell culture medium and growth conditions
The human THP-1 monocytic cells (THP-1) [26] were grown in
cell culture medium - RPMI 1640 supplemented with 20% FCS,
glutamine (2 mM), streptomycin/penicillin (100 mg/mL/100 U/
mL), sodium pyruvate (2 mM) and Non-Essential Amino Acids
Solution at 37uC, in a humidified atmosphere of 95% air and 5%
CO2.
Inflammation assay
THP-1 cells (2610
6 cells/ml) were incubated in 96-well tissue
culture plates in serum-free culture medium. Cells were treated
with bacteria extracellular stock solution (see sample preparation)
in a 1/80 dilution in distilled water or as indicated, for 12 hours.
The medium was then harvested and assayed for TNF-alpha levels
by sandwich ELISA using 4 mg/ml Anti-Human TNF-alpha
(peprotech), 0.5 mg/ml Biotinylated Anti-Human TNF-alpha
(peprotech), 0.1 mg/ml Streptavidin- HRP (Enco) and TMB
(RandD). Untreated THP-1 cells were used as blank and
concentrated MOPS was used as a control.
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